Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions.
about
Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation.Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotypeBMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-IIConversion of the nipple to hair-bearing epithelia by lowering bone morphogenetic protein pathway activity at the dermal-epidermal interfaceBone morphogenetic protein-9. An autocrine/paracrine cytokine in the liverNoggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation.Psoriatic arthritis: a unified concept twenty years on.Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopeciaEnhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis.Skin as a living coloring book: how epithelial cells create patterns of pigmentation.Sleep loss and cytokines levels in an experimental model of psoriasis.BMP-FGF signaling axis mediates Wnt-induced epidermal stratification in developing mammalian skin.Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in miceGenetically modified mice as a tool to study inflammatory skin diseases.Animal models of psoriasis.A pair of transmembrane receptors essential for the retention and pigmentation of hair.Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA.BMP signaling in dermal papilla cells is required for their hair follicle-inductive propertiesThe evolution of the psoriatic lesion.Aquaporin gene therapy corrects Sjögren's syndrome phenotype in miceInnate immunity and antimicrobial defense systems in psoriasis.Bone morphogenetic protein antagonist noggin promotes skin tumorigenesis via stimulation of the Wnt and Shh signaling pathways.E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes.Serum Proteomic Analysis Based on iTRAQ in Miners Exposed to Soil Containing Rare Earth Elements.The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells.Overexpression of constitutively active BMP-receptor-IB in mouse skin causes an ichthyosis-vulgaris-like disease.BMP signaling induces cell-type-specific changes in gene expression programs of human keratinocytes and fibroblasts.Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model.Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammationDown-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis.Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis.Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis.mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation.
P2860
Q24537740-19B4C862-854B-421C-8BB0-F3E84EAFC2A8Q24561448-3795F9DA-B1EE-4337-910E-93D1BCC81C4EQ24631766-EF7D9F0C-5E8B-4E5A-8575-960723E60BAFQ24650757-EBA1C0A4-7150-4D6C-8A62-A2FF752ED7D7Q28137973-9B3D7D87-3DAE-43C6-BCE8-A2BE496891DBQ30452954-E4CA36C9-4545-4681-81A7-31471FCDFDDDQ33656096-17062F46-100B-4E79-9927-D64FE32614ACQ33930015-98EFFE74-301B-4318-9813-B0E8DEF9D2F4Q34277301-E90EA135-5E6A-4BB2-A525-4FC04CDD0ED7Q34415873-31EFF612-BC1C-428C-B329-077107B8D780Q34506348-2DD46F4B-FAB3-4A25-B35D-772800D2378EQ35348773-E2E81CCE-1679-40D1-A7D0-65C37EF19814Q35902283-AD94E978-A0ED-4C2C-9B89-3093E647B1E9Q35923627-9AFB30AE-9160-4069-854F-E10E1D732BBCQ35997885-AFC6AA36-243F-46EE-B791-80E7CABC37AFQ36181290-576899CD-A772-42EA-817B-BA6861EEFE8CQ36288327-035E190C-F88A-4CC8-95BB-226B5623B164Q36324810-971DDB83-D582-42A1-A784-E964EFE435B2Q36453561-E2B12195-6992-464E-9D53-22B882A0EAAEQ36853157-1EE3C741-9F22-48AA-8A01-8176DFACF50FQ36931123-C911E5AE-F36E-4A8E-9742-29D370F74077Q37005309-5B6542EC-4C7A-465F-B76F-F7FFAB434336Q37316577-63CB3BE6-603D-440E-B09F-C7BC1498E51EQ38310994-E4B588F7-BF8A-49AB-9497-E64B40AF203BQ39026228-B7110C2B-99C2-43F4-8D6A-57BB6E4C30E0Q40810927-8E08A297-8CF4-4327-B1A3-A03F04419D9FQ41661456-3938DAEF-B9DB-4A42-B98A-54BFC7C41798Q41968524-00B62665-2F5F-4AF1-8433-A68E90BEFA6AQ42012250-8E37F5D4-F429-48B0-B7F2-A3633F8FED68Q42415954-C8B1C752-8DA3-4E17-8E88-98642FB58709Q42453452-37A693DA-26FD-429F-B255-90A21BC5EFBCQ42462805-DA28CB05-4C7E-414F-B8FB-1CABF9432226Q42503191-DAF4BDE0-74EE-464A-BB9C-88FF32A8D7CEQ47748656-3218441A-D3FE-432A-BA4F-611DE78C9CFD
P2860
Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Overexpression of bone morphog ...... ormation of psoriatic lesions.
@ast
Overexpression of bone morphog ...... ormation of psoriatic lesions.
@en
type
label
Overexpression of bone morphog ...... ormation of psoriatic lesions.
@ast
Overexpression of bone morphog ...... ormation of psoriatic lesions.
@en
prefLabel
Overexpression of bone morphog ...... ormation of psoriatic lesions.
@ast
Overexpression of bone morphog ...... ormation of psoriatic lesions.
@en
P2093
P2860
P356
P1476
Overexpression of bone morphog ...... ormation of psoriatic lesions.
@en
P2093
M Blessing
P Schirmacher
P2860
P304
P356
10.1083/JCB.135.1.227
P407
P577
1996-10-01T00:00:00Z